home · filing · 0001903596-24-000563
8-K
filed August 28, 2024, 7:59 PM ET
ticker LUDG
CIK 0001960262
leadership
confidence high
sentiment neutral
materiality 0.60
Ludwig Enterprises appoints Jose Antonio Reyes as CEO; Dr. Hausman resigns but remains Director & CSO
LUDWIG ENTERPRISES, INC.
Dr. Marvin S. Hausman resigned as CEO effective August 20, 2024; no disagreement with company operations.
Jose Antonio Reyes appointed as CEO immediately; background includes roles at BlockScience, IGM Global, and Excelorators.
Dr. Hausman continues to serve as a Director and Chief Science Officer of the company.
Reyes has experience as founder, COO, and business development director across multiple organizations.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-08-20
Successor Jose Antonio Reyes
Filed August 28, 2024, 7:59 PM ET
Marvin S. Hausman, M.D. resigned as Chief Executive Officer, effective immediately.
Effective 2024-08-20
Filed August 28, 2024, 7:59 PM ET
the Board appointed a new Chief Executive Officer, Jose Antonio Reyes, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Marvin S. Hausman resigned as Chief Executive Officer at LUDWIG ENTERPRISES, INC..
Action resigned
Role Chief Executive Officer
Exact text from the filing
Marvin S. Hausman, M.D. resigned as Chief Executive Officer, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jose Antonio Reyes was appointed as Chief Executive Officer at LUDWIG ENTERPRISES, INC..
Action appointed
Role Chief Executive Officer
Exact text from the filing
the Board appointed a new Chief Executive Officer, Jose Antonio Reyes, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001903596-24-000563
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.